Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Therapy Approaches
100%
Non-Hodgkin Lymphoma
100%
Novel Combination Therapy
100%
Clinical Response
66%
Oncolytic Virus
50%
Tumor Microenvironment
50%
Vesicular Stomatitis Virus
50%
Mechanism of Action
33%
Tumor
33%
Tumor Antigen
16%
Tumor Killing
16%
Clinical Toxicity
16%
Phagocytosis
16%
Immunotherapy Resistance
16%
Disseminated Cancer
16%
Virus Therapy
16%
Innate Mechanisms
16%
Mayo Clinic
16%
Oncoimmunology
16%
Macrophage Cells
16%
Limited Overlap
16%
Tumor Architecture
16%
Dual-target
16%
Valuable Insight
16%
Poor Prognosis
16%
University of Minnesota
16%
Anti-tumor T Cell Response
16%
Human Cancer
16%
T Cells
16%
Canine
16%
Most Common Form
16%
Immune Response
16%
Lymphoma
16%
Immunogenic
16%
Tumor-immune System
16%
Systemic Therapy
16%
Comparative Oncology
16%
Viral Lysis
16%
Hodgkin Lymphoma
16%
Antigen Presentation
16%
Genome Comparison
16%
Veterinary Clinical Trials
16%
Refractory DLBCL
16%
Two-species
16%
Tumor Cells
16%
Checkpoint Blockade
16%
Chemotherapy Protocols
16%
Immune Infiltration
16%
Adaptive Mechanism
16%
Murine Tumor Model
16%
Complementary Mechanism
16%
Relapsed or Refractory
16%
Clinical Utility
16%
Antitumor Immune Response
16%
Unmet
16%
Medicine and Dentistry
Combination Therapy
100%
Non-Hodgkin Lymphoma
100%
Diffuse Large B-Cell Lymphoma
100%
Neoplasm
85%
Immunotherapy
57%
Vesiculovirus
42%
Tumor Microenvironment
42%
Oncolytic Virus
42%
Cancer
28%
T-Cell Response
14%
Macrophage
14%
Immune Response
14%
Tumor Antigen
14%
Virotherapy
14%
Tumor Cell
14%
Tumor Model
14%
T Cell
14%
Systemic Therapy
14%
Biological Marker
14%
Oncology
14%
Disseminated Cancer
14%
Virogenesis
14%
Antigen Presentation
14%
Immune Cell Infiltration
14%
Phagocytosis
14%
Hodgkin's Lymphoma
14%
Immunology and Microbiology
Immunotherapy
100%
Oncolytic Virus
75%
Vesiculovirus
75%
T Cell
50%
Immune Response
25%
Macrophage
25%
Tumor Cell
25%
Virogenesis
25%
B Cell
25%
Virotherapy
25%
Antigen Presentation
25%
Immune Cell Infiltration
25%
Murine
25%
Phagocytosis
25%
Tumor Antigen
25%